I. Litvin

发表

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.

B. Leyland-Jones, E. Vercammen, I. Bondarenko, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract S5-07: A randomized, open-label, multicenter, phase 3 study of epoetin alfa (EPO) plus standard supportive care versus standard supportive care in anemic patients with metastatic breast cancer (MBC) receiving standard chemotherapy

B. Leyland-Jones, K. Lakshmaiah, E. Vercammen, 2015 .